drugset / Trial / NCT05034952
A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of VX-548 doses in treating acute pain after an abdominoplasty.
Timeline
- Start
- 2021-08-30
- Primary completion
- 2021-12-05
- Completion
- 2021-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Acetaminophen | Small molecule | 325 mg | Oral |
| Subject | Suzetrigine | Small molecule | 30 mg | Oral |
| Subject | Suzetrigine | Small molecule | 50 mg | Oral |
| Comparator | hydrocodone bitartrate | Unknown | 5 mg | Oral |
Indications
No indication recorded.